CLGN
Price
$2.04
Change
+$0.06 (+3.03%)
Updated
May 21 closing price
Capitalization
23.37M
6 days until earnings call
CMVLF
Price
$1.25
Change
-$0.25 (-16.67%)
Updated
Jan 2 closing price
Capitalization
151.23M
Interact to see
Advertisement

CLGN vs CMVLF

Header iconCLGN vs CMVLF Comparison
Open Charts CLGN vs CMVLFBanner chart's image
CollPlant Biotechnologies
Price$2.04
Change+$0.06 (+3.03%)
Volume$5.63K
Capitalization23.37M
Cellectis Romainville
Price$1.25
Change-$0.25 (-16.67%)
Volume$1.6K
Capitalization151.23M
CLGN vs CMVLF Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLGN vs. CMVLF commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGN is a Hold and CMVLF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (CLGN: $2.04 vs. CMVLF: $1.25)
Brand notoriety: CLGN and CMVLF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLGN: 42% vs. CMVLF: 100%
Market capitalization -- CLGN: $23.37M vs. CMVLF: $151.23M
CLGN [@Biotechnology] is valued at $23.37M. CMVLF’s [@Biotechnology] market capitalization is $151.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLGN’s FA Score shows that 1 FA rating(s) are green whileCMVLF’s FA Score has 1 green FA rating(s).

  • CLGN’s FA Score: 1 green, 4 red.
  • CMVLF’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLGN and CMVLF are a bad buy in the long-term.

Price Growth

CLGN (@Biotechnology) experienced а +24.77% price change this week, while CMVLF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.18%. For the same industry, the average monthly price growth was +6.79%, and the average quarterly price growth was -1.65%.

Reported Earning Dates

CLGN is expected to report earnings on Aug 21, 2025.

Industries' Descriptions

@Biotechnology (+4.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
CMVLF($151M) has a higher market cap than CLGN($23.4M). CMVLF YTD gains are higher at: -16.667 vs. CLGN (-43.333). CMVLF has higher annual earnings (EBITDA): -9.46M vs. CLGN (-17.27M). CMVLF has more cash in the bank: 260M vs. CLGN (15.4M). CLGN has less debt than CMVLF: CLGN (3.25M) vs CMVLF (91.5M). CMVLF has higher revenues than CLGN: CMVLF (41.5M) vs CLGN (650K).
CLGNCMVLFCLGN / CMVLF
Capitalization23.4M151M15%
EBITDA-17.27M-9.46M182%
Gain YTD-43.333-16.667260%
P/E RatioN/AN/A-
Revenue650K41.5M2%
Total Cash15.4M260M6%
Total Debt3.25M91.5M4%
FUNDAMENTALS RATINGS
CLGN vs CMVLF: Fundamental Ratings
CLGN
CMVLF
OUTLOOK RATING
1..100
243
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9484
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CMVLF's Valuation (20) in the null industry is significantly better than the same rating for CLGN (94) in the Biotechnology industry. This means that CMVLF’s stock grew significantly faster than CLGN’s over the last 12 months.

CMVLF's Profit vs Risk Rating (100) in the null industry is in the same range as CLGN (100) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to CLGN’s over the last 12 months.

CMVLF's SMR Rating (100) in the null industry is in the same range as CLGN (100) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to CLGN’s over the last 12 months.

CMVLF's Price Growth Rating (84) in the null industry is in the same range as CLGN (94) in the Biotechnology industry. This means that CMVLF’s stock grew similarly to CLGN’s over the last 12 months.

CLGN's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for CMVLF (100) in the null industry. This means that CLGN’s stock grew significantly faster than CMVLF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VOR0.18N/A
+2.35%
Vor Biopharma
JMSB17.50N/A
N/A
John Marshall Bancorp
GRMN200.74-3.02
-1.48%
Garmin Ltd
CRCT6.11-0.15
-2.40%
Cricut
SEDG19.84-0.81
-3.92%
SolarEdge Technologies

CLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLGN has been loosely correlated with CMVLF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CLGN jumps, then CMVLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
+3.03%
CMVLF - CLGN
37%
Loosely correlated
N/A
CLLS - CLGN
33%
Poorly correlated
-1.30%
VOR - CLGN
25%
Poorly correlated
+2.35%
INTS - CLGN
24%
Poorly correlated
-9.59%
CVAC - CLGN
24%
Poorly correlated
-8.88%
More

CMVLF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMVLF has been closely correlated with CLLS. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if CMVLF jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMVLF
1D Price
Change %
CMVLF100%
N/A
CLLS - CMVLF
78%
Closely correlated
-1.30%
ABCZF - CMVLF
59%
Loosely correlated
N/A
SLN - CMVLF
41%
Loosely correlated
N/A
ALDX - CMVLF
39%
Loosely correlated
-4.66%
CLGN - CMVLF
37%
Loosely correlated
+3.03%
More